Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125174522 | 12517452 | 2 | F | 2014 | 20160721 | 20160630 | 20160802 | PER | US-ASTRAZENECA-2016SE68086 | ASTRAZENECA | 80.00 | YR | Y | 70.80000 | KG | 20160802 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125174522 | 12517452 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1145539 | 202450 | INHALATION POWDER | |||||||||
| 125174522 | 12517452 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1145539 | 202450 | INHALATION POWDER | |||||||||
| 125174522 | 12517452 | 3 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG, 1 PUFF DAILY | 202450 | INHALATION POWDER | |||||||||
| 125174522 | 12517452 | 4 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG, 1 PUFF DAILY | 202450 | INHALATION POWDER | |||||||||
| 125174522 | 12517452 | 5 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | STARTED DURING 2007-2008, 1 PUFF 2 TIMES DAILY | 0 | ||||||||||
| 125174522 | 12517452 | 6 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | STARTED DURING 2007-2008, 1 PUFF 2 TIMES DAILY | 0 | ||||||||||
| 125174522 | 12517452 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 1 PUFF 2 TIMES DAILY REPEAT 1 PUFF AS REQUIRED | 0 | |||||||||||
| 125174522 | 12517452 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 1 PUFF 2 TIMES DAILY REPEAT 1 PUFF AS REQUIRED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125174522 | 12517452 | 1 | Chronic obstructive pulmonary disease |
| 125174522 | 12517452 | 2 | Emphysema |
| 125174522 | 12517452 | 3 | Chronic obstructive pulmonary disease |
| 125174522 | 12517452 | 4 | Emphysema |
| 125174522 | 12517452 | 5 | Chronic obstructive pulmonary disease |
| 125174522 | 12517452 | 6 | Emphysema |
| 125174522 | 12517452 | 7 | Chronic obstructive pulmonary disease |
| 125174522 | 12517452 | 8 | Emphysema |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125174522 | 12517452 | Chronic obstructive pulmonary disease | |
| 125174522 | 12517452 | Off label use | |
| 125174522 | 12517452 | Osteoarthritis | |
| 125174522 | 12517452 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125174522 | 12517452 | 3 | 2014 | 0 | ||
| 125174522 | 12517452 | 4 | 2014 | 0 | ||
| 125174522 | 12517452 | 7 | 201605 | 0 | ||
| 125174522 | 12517452 | 8 | 201605 | 0 |